Beena Thannickal
| This email address is being protected from spambots. You need JavaScript enabled to view it.Media Specialist, UAB News
(205) 975-3967
beenat@uab.edu
Thannickal recently moved to Birmingham from Ann Arbor, Mich., where she was the senior PR specialist at the Institute for Research on Women and Gender at the University of Michigan. She previously worked at Boston University, specializing in research and science news, and she worked at PR firms in New York and Boston. While raising her three children she was a freelance writer for a women’s health magazine and a PR consultant for national clients. Beena’s professional roots started in Connecticut where she worked as a reporter at news organizations throughout the state. She has a bachelor's degree in journalism from the University of Connecticut. In her very little spare time, she likes to run and travel.
Beats: The UAB Comprehensive Cancer Center, cancer patient stories, cancer-related research
(205) 975-3967
beenat@uab.edu
Thannickal recently moved to Birmingham from Ann Arbor, Mich., where she was the senior PR specialist at the Institute for Research on Women and Gender at the University of Michigan. She previously worked at Boston University, specializing in research and science news, and she worked at PR firms in New York and Boston. While raising her three children she was a freelance writer for a women’s health magazine and a PR consultant for national clients. Beena’s professional roots started in Connecticut where she worked as a reporter at news organizations throughout the state. She has a bachelor's degree in journalism from the University of Connecticut. In her very little spare time, she likes to run and travel.
Beats: The UAB Comprehensive Cancer Center, cancer patient stories, cancer-related research
New UAB research study shows therapeutic promise in targeting MLK4 in brain cancer patients.
In a joint statement of National Cancer Institute-designated cancer centers, the UAB Comprehensive Cancer Center urges parents, young adults and physicians to increase HPV vaccination rates.
The Nov. 10 workshop will provide information and resources for lung cancer patients.
UAB researcher reports that brentuximab vedotin may be effective therapy for older patients with Hodgkin Lymphoma who cannot tolerate standard therapy.
Several activities are planned in and around UAB for Breast Cancer Awareness Month.
Many UAB physicians from a variety of specialties appear on the prestigious Newsweek Top Cancer Doctors 2015 list.
New UAB research demonstrates social factors that determine survival of younger patients with AML and present opportunities to improve outcomes.
UAB’s Karan Singh has been selected as an American Statistical Association Fellow and recognized as a foremost member in the field of statistical science.
UAB offers two national clinical trials with customized treatment for lung cancer patients.
UAB presented an observational study at this week’s annual American Society of Clinical Oncology meeting in Chicago that indicates a more rapid decline in Medicare costs and patient resource utilization during implementation of a lay navigation program.